Selected research
Market Structure
Global Contraceptive Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Contraceptive Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Contraceptive Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Contraceptive Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Contraceptive Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Contraceptive Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Contraceptive Devices include Actavis, Agile Therapeutics, Ansell, Caya, Church & Dwight, Condomi Health, HLL Lifecare, Karex Industries and Medicines360, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Contraceptive Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Contraceptive Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Contraceptive Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contraceptive Devices market size, projected growth trends, production technologies, key applications, and end-use industries.
Contraceptive Devices Segment by Company
Actavis
Agile Therapeutics
Ansell
Caya
Church & Dwight
Condomi Health
HLL Lifecare
Karex Industries
Medicines360
Okamoto Industries
The Female Health Company
TodaySponge
Bayer
Merck & Co
Teva Pharmaceutical
Contraceptive Devices Segment by Type
Male Contraceptive Devices
Female Contraceptive Devices
Contraceptive Devices Segment by Application
E-Commerce
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
Others
Contraceptive Devices Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Contraceptive Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contraceptive Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Contraceptive Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Contraceptive Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Male Contraceptive Devices
- Female Contraceptive Devices
Applications
- E-Commerce
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
- Others
Companies covered
- Actavis
- Agile Therapeutics
- Ansell
- Caya
- Church & Dwight
- Condomi Health
- HLL Lifecare
- Karex Industries
- Medicines360
- Okamoto Industries
- The Female Health Company
- TodaySponge
- Bayer
- Merck & Co
- Teva Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Contraceptive Devices Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Contraceptive Devices Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Contraceptive Devices Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Contraceptive Devices Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Contraceptive Devices Market Dynamics
- 2.1 Contraceptive Devices Industry Trends
- 2.2 Contraceptive Devices Industry Drivers
- 2.3 Contraceptive Devices Industry Opportunities and Challenges
- 2.4 Contraceptive Devices Industry Restraints
3 Contraceptive Devices Market by Manufacturers
- 3.1 Global Contraceptive Devices Revenue by Manufacturers (2021-2026)
- 3.2 Global Contraceptive Devices Sales by Manufacturers (2021-2026)
- 3.3 Global Contraceptive Devices Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Contraceptive Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Contraceptive Devices Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Contraceptive Devices Manufacturers, Product Type & Application
- 3.7 Global Contraceptive Devices Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Contraceptive Devices Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Contraceptive Devices Players Market Share by Revenue in 2025
- 3.8.3 2025 Contraceptive Devices Tier 1, Tier 2, and Tier 3
4 Contraceptive Devices Market by Type
- 4.1 Contraceptive Devices Type Introduction
- 4.1.1 Male Contraceptive Devices
- 4.1.2 Female Contraceptive Devices
- 4.2 Global Contraceptive Devices Sales by Type
- 4.2.1 Global Contraceptive Devices Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Contraceptive Devices Sales by Type (2021-2032)
- 4.2.3 Global Contraceptive Devices Sales Market Share by Type (2021-2032)
- 4.3 Global Contraceptive Devices Revenue by Type
- 4.3.1 Global Contraceptive Devices Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Contraceptive Devices Revenue by Type (2021-2032)
- 4.3.3 Global Contraceptive Devices Revenue Market Share by Type (2021-2032)
5 Contraceptive Devices Market by Application
- 5.1 Contraceptive Devices Application Introduction
- 5.1.1 E-Commerce
- 5.1.2 Retail Pharmacy
- 5.1.3 Online Pharmacy
- 5.1.4 Hospital Pharmacy
- 5.1.5 Others
- 5.2 Global Contraceptive Devices Sales by Application
- 5.2.1 Global Contraceptive Devices Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Contraceptive Devices Sales by Application (2021-2032)
- 5.2.3 Global Contraceptive Devices Sales Market Share by Application (2021-2032)
- 5.3 Global Contraceptive Devices Revenue by Application
- 5.3.1 Global Contraceptive Devices Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Contraceptive Devices Revenue by Application (2021-2032)
- 5.3.3 Global Contraceptive Devices Revenue Market Share by Application (2021-2032)
6 Global Contraceptive Devices Sales by Region
- 6.1 Global Contraceptive Devices Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Contraceptive Devices Sales by Region (2021-2032)
- 6.2.1 Global Contraceptive Devices Sales by Region (2021-2026)
- 6.2.2 Global Contraceptive Devices Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Contraceptive Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Contraceptive Devices Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Contraceptive Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Contraceptive Devices Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Contraceptive Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Contraceptive Devices Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Contraceptive Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Contraceptive Devices Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Contraceptive Devices Revenue by Region
- 7.1 Global Contraceptive Devices Revenue by Region
- 7.1.1 Global Contraceptive Devices Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Contraceptive Devices Revenue by Region (2021-2026)
- 7.1.3 Global Contraceptive Devices Revenue by Region (2027-2032)
- 7.1.4 Global Contraceptive Devices Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Contraceptive Devices Revenue (2021-2032)
- 7.2.2 North America Contraceptive Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Contraceptive Devices Revenue (2021-2032)
- 7.3.2 Europe Contraceptive Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Contraceptive Devices Revenue (2021-2032)
- 7.4.2 Asia-Pacific Contraceptive Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Contraceptive Devices Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Contraceptive Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Actavis
- 8.1.1 Actavis Company Information
- 8.1.2 Actavis Business Overview
- 8.1.3 Actavis Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Actavis Contraceptive Devices Product Portfolio
- 8.1.5 Actavis Recent Developments
- 8.2 Agile Therapeutics
- 8.2.1 Agile Therapeutics Company Information
- 8.2.2 Agile Therapeutics Business Overview
- 8.2.3 Agile Therapeutics Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Agile Therapeutics Contraceptive Devices Product Portfolio
- 8.2.5 Agile Therapeutics Recent Developments
- 8.3 Ansell
- 8.3.1 Ansell Company Information
- 8.3.2 Ansell Business Overview
- 8.3.3 Ansell Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Ansell Contraceptive Devices Product Portfolio
- 8.3.5 Ansell Recent Developments
- 8.4 Caya
- 8.4.1 Caya Company Information
- 8.4.2 Caya Business Overview
- 8.4.3 Caya Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Caya Contraceptive Devices Product Portfolio
- 8.4.5 Caya Recent Developments
- 8.5 Church & Dwight
- 8.5.1 Church & Dwight Company Information
- 8.5.2 Church & Dwight Business Overview
- 8.5.3 Church & Dwight Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Church & Dwight Contraceptive Devices Product Portfolio
- 8.5.5 Church & Dwight Recent Developments
- 8.6 Condomi Health
- 8.6.1 Condomi Health Company Information
- 8.6.2 Condomi Health Business Overview
- 8.6.3 Condomi Health Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Condomi Health Contraceptive Devices Product Portfolio
- 8.6.5 Condomi Health Recent Developments
- 8.7 HLL Lifecare
- 8.7.1 HLL Lifecare Company Information
- 8.7.2 HLL Lifecare Business Overview
- 8.7.3 HLL Lifecare Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 HLL Lifecare Contraceptive Devices Product Portfolio
- 8.7.5 HLL Lifecare Recent Developments
- 8.8 Karex Industries
- 8.8.1 Karex Industries Company Information
- 8.8.2 Karex Industries Business Overview
- 8.8.3 Karex Industries Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Karex Industries Contraceptive Devices Product Portfolio
- 8.8.5 Karex Industries Recent Developments
- 8.9 Medicines360
- 8.9.1 Medicines360 Company Information
- 8.9.2 Medicines360 Business Overview
- 8.9.3 Medicines360 Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Medicines360 Contraceptive Devices Product Portfolio
- 8.9.5 Medicines360 Recent Developments
- 8.10 Okamoto Industries
- 8.10.1 Okamoto Industries Company Information
- 8.10.2 Okamoto Industries Business Overview
- 8.10.3 Okamoto Industries Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Okamoto Industries Contraceptive Devices Product Portfolio
- 8.10.5 Okamoto Industries Recent Developments
- 8.11 The Female Health Company
- 8.11.1 The Female Health Company Company Information
- 8.11.2 The Female Health Company Business Overview
- 8.11.3 The Female Health Company Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 The Female Health Company Contraceptive Devices Product Portfolio
- 8.11.5 The Female Health Company Recent Developments
- 8.12 TodaySponge
- 8.12.1 TodaySponge Company Information
- 8.12.2 TodaySponge Business Overview
- 8.12.3 TodaySponge Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 TodaySponge Contraceptive Devices Product Portfolio
- 8.12.5 TodaySponge Recent Developments
- 8.13 Bayer
- 8.13.1 Bayer Company Information
- 8.13.2 Bayer Business Overview
- 8.13.3 Bayer Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Bayer Contraceptive Devices Product Portfolio
- 8.13.5 Bayer Recent Developments
- 8.14 Merck & Co
- 8.14.1 Merck & Co Company Information
- 8.14.2 Merck & Co Business Overview
- 8.14.3 Merck & Co Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Merck & Co Contraceptive Devices Product Portfolio
- 8.14.5 Merck & Co Recent Developments
- 8.15 Teva Pharmaceutical
- 8.15.1 Teva Pharmaceutical Company Information
- 8.15.2 Teva Pharmaceutical Business Overview
- 8.15.3 Teva Pharmaceutical Contraceptive Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Teva Pharmaceutical Contraceptive Devices Product Portfolio
- 8.15.5 Teva Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Contraceptive Devices Value Chain Analysis
- 9.1.1 Contraceptive Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Contraceptive Devices Production Mode & Process
- 9.2 Contraceptive Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Contraceptive Devices Distributors
- 9.2.3 Contraceptive Devices Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst